Case study : How Delpharm serves HMNC Brain Health in its phase II clinical trial

Published on

DELPHARM Development and CREAPHARM CLINICAL SUPPLIES have collaborated to fully meet HMNC Brain Health’s need and makes its task easier while handling end-to-end operations for both non-GMP technical batches and clinical batches.

HMNC Brain Health is a disruptive clinical stage biopharmaceutical company pioneering Precision Psychiatry, powered by its AI Platform, and focusing on Treatment-Resistant Depression (TRD) and Major Depressive Disorder (MDD).

Case study PDF - 1.3 MiB